President Donald Trump signed an executive order this week that seeks to dramatically reshape vaccine policy in the United States, including a change that contradicts one of his other stated goals: to ...

The Labor Department appears to be considering entering into a settlement agreement with entities that use a loophole to sell ...

US President Donald Trump has opened a new front in his administration’s sweeping overhaul of childhood vaccination policy: he wants the measles, mumps and rubella vaccine – commonly known as MMR – to ...

President Trump's new executive order on vaccines raises a number of public health concerns. A physician breaks those down.

Replimune Group, Inc. (NASDAQ: REPL), a commercial stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the U.S. Food and Drug Administration ...

Explore the implications of AI in designing viruses, highlighting opportunities in medicine and biosecurity challenges.

Cemsidomide’s Ongoing Phase 2 MOMENTUM Trial and Phase 1b Trial in Combination With Elranatamab Remain on Track to Deliver Clinical Data Readouts ...

By Jacob Bogage, Ahmed Aboulenein and Julie Steenhuysen WASHINGTON, Aug 10 (Reuters) - U.S. President Donald Trump signed an executive order on Monday calling for fewer childhood vaccinations by ...

Dispatch Bio begins patient dosing in phase 1 study of DISP-10, a novel investigational immunotherapy, in advanced gastrointestinal cancers: Philadelphia, San Francisco Saturday, ...

Replimune Group, Inc. (Nasdaq: REPL) (“Replimune”), a commercial-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the pricing of an ...

US President Donald Trump has signed an executive order calling for fewer childhood vaccinations by limiting the inoculation schedule to 11 immunisations, which he said would give ...

US President Donald Trump signed an executive order on Monday calling for fewer childhood vaccinations by limiting the ...